These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 19540329)

  • 1. Characterization of the phospholipidogenic potential of 4(1H)-pyridone antimalarial derivatives.
    Almela MJ; Torres PA; Lozano S; Herreros E
    Toxicol In Vitro; 2009 Dec; 23(8):1528-34. PubMed ID: 19540329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S; Matsumoto A; Mori I; Horinouchi A
    Toxicol Mech Methods; 2009 Oct; 19(8):477-85. PubMed ID: 19793005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of an in vitro screen for phospholipidosis using a high-content biology platform.
    Morelli JK; Buehrle M; Pognan F; Barone LR; Fieles W; Ciaccio PJ
    Cell Biol Toxicol; 2006 Jan; 22(1):15-27. PubMed ID: 16463016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipidosis assay in HepG2 cells and rat or rhesus hepatocytes using phospholipid probe NBD-PE.
    Bhandari N; Figueroa DJ; Lawrence JW; Gerhold DL
    Assay Drug Dev Technol; 2008 Jun; 6(3):407-19. PubMed ID: 18537465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies.
    Nioi P; Perry BK; Wang EJ; Gu YZ; Snyder RD
    Toxicol Sci; 2007 Sep; 99(1):162-73. PubMed ID: 17567588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High content screening analysis of phospholipidosis: validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis.
    van de Water FM; Havinga J; Ravesloot WT; Horbach GJ; Schoonen WG
    Toxicol In Vitro; 2011 Dec; 25(8):1870-82. PubMed ID: 21651975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids.
    Takagi M; Sanoh S; Santoh M; Ejiri Y; Kotake Y; Ohta S
    J Toxicol Sci; 2016 Feb; 41(1):155-64. PubMed ID: 26763403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
    Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
    Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced phospholipidosis is caused by blockade of mannose 6-phosphate receptor-mediated targeting of lysosomal enzymes.
    Ikeda K; Hirayama M; Hirota Y; Asa E; Seki J; Tanaka Y
    Biochem Biophys Res Commun; 2008 Dec; 377(1):268-74. PubMed ID: 18840403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H; Dekura E; Kurabe M; Shimazu N; Koitabashi M; Toriumi W
    Exp Toxicol Pathol; 2007 Aug; 58(6):375-82. PubMed ID: 17408938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.
    Atienzar F; Gerets H; Dufrane S; Tilmant K; Cornet M; Dhalluin S; Ruty B; Rose G; Canning M
    Toxicol Sci; 2007 Mar; 96(1):101-14. PubMed ID: 17175557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
    Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
    Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of 4(1H)-pyridones as a novel family of potent antimalarial inhibitors of the plasmodial cytochrome bc1.
    Bueno JM; Herreros E; Angulo-Barturen I; Ferrer S; Fiandor JM; Gamo FJ; Gargallo-Viola D; Derimanov G
    Future Med Chem; 2012 Dec; 4(18):2311-23. PubMed ID: 23234553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 4-pyridones as potential antimalarials.
    Yeates CL; Batchelor JF; Capon EC; Cheesman NJ; Fry M; Hudson AT; Pudney M; Trimming H; Woolven J; Bueno JM; Chicharro J; Fernández E; Fiandor JM; Gargallo-Viola D; Gómez de las Heras F; Herreros E; León ML
    J Med Chem; 2008 May; 51(9):2845-52. PubMed ID: 18396855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and validation of multiple cell lines and primary mouse macrophages to predict phospholipidosis potential.
    LeCureux L; Cheng CS; Herbst J; Reilly TP; Lehman-McKeeman L; Otieno M
    Toxicol In Vitro; 2011 Dec; 25(8):1934-43. PubMed ID: 21767630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
    Tilmant K; Gerets HH; Dhalluin S; Hanon E; Depelchin O; Cossu-Leguille C; Vasseur P; Atienzar FA
    Toxicol In Vitro; 2011 Oct; 25(7):1414-24. PubMed ID: 21515356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptation of an in vitro phospholipidosis assay to an automated image analysis system.
    Schurdak ME; Vernetti LA; Abel SJ; Thiffault C
    Toxicol Mech Methods; 2007; 17(2):77-86. PubMed ID: 20020975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase.
    Natalie M; Margino S; Erik H; Annelieke P; Geert V; Philippe V
    Toxicol In Vitro; 2009 Mar; 23(2):217-26. PubMed ID: 19101623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds.
    Hanumegowda UM; Wenke G; Regueiro-Ren A; Yordanova R; Corradi JP; Adams SP
    Chem Res Toxicol; 2010 Apr; 23(4):749-55. PubMed ID: 20356072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for the drug-phospholipid interaction: correlation to phospholipidosis.
    Alakoskela JM; Vitovic P; Kinnunen PK
    ChemMedChem; 2009 Aug; 4(8):1224-51. PubMed ID: 19551800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.